Drugs Made In America Acquisition Corp. - UNIT 10/15/2029 (DMAAU)

CUSIP: G2847J120

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / UNIT 10/15/2029
Total 13F shares
986,129
Share change
-2,303,094
Total reported value
$10,176,850
Price per share
$10.32
Number of holders
9
Value change
-$23,363,644
Number of buys
3
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP G2847J120?
CUSIP G2847J120 identifies DMAAU - Drugs Made In America Acquisition Corp. - UNIT 10/15/2029 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Drugs Made In America Acquisition Corp. - UNIT 10/15/2029 (DMAAU) as of Q2 2025

As of 30 Jun 2025, Drugs Made In America Acquisition Corp. - UNIT 10/15/2029 (DMAAU) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 986,129 shares. The largest 9 holders included RIVERNORTH CAPITAL MANAGEMENT, LLC, Context Capital Management, LLC, WOLVERINE ASSET MANAGEMENT LLC, Bulldog Investors, LLP, CLEAR STREET LLC, ROBINSON CAPITAL MANAGEMENT, LLC, Tuttle Capital Management, LLC, UBS Group AG, and CITADEL ADVISORS LLC. This page lists 9 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.